Taiwan biotechnology, pharmaceutical, medical devices
Singapore-headquartered ASLAN Pharmaceuticals (ASLAN, 6497.TT), a biotech company focused on the development of immunotherapies and targeted treatments for Asia prevalent cancer types, recently announced the signing of a research collaboration agreement with Academia Sinica’s Genomic Research Centre, one of Taiwan’s leading research institutions.
Read moreTaiwan’s Michael Ming-Chiao Lai, former vice president of Academia Sinica and researcher at its Institute of Molecular Biology, has been announced this year’s winner of the Nikkei Asia Prize in the category of Science, Technology and Innovation.
Read moreBy Dave Silver
March 31, 2017
A Taiwanese study presented yesterday at an international conference on Alzheimer’s and Parkinson’s diseases suggested that long-term use of the popular diabetes medication Metformin may increase the risk of neurodegenerative disease in patients with type 2 diabetes mellitus, contradicting the results of a large study published just last year following US-based subjects that seemed to show that Metformin exerts a protective effect against the same diseases.
After his late wife’s battle with breast cancer, Hon Hai Precision Industry chairman and Taiwan’s richest man Terry Gou started the Yonglin Healthcare Foundation, with the aim of using the best of technology wherever it was developed to take the fight to this disease.
Read moreOur featured event is BioTaiwan 2017, the annual week-long festival of life science-themed conferences, exhibitions and gatherings held in Taipei, Taiwan.
Read more
